Download PDF
Zeitschrift für Komplementärmedizin 2016; 08(05): 48-53
DOI: 10.1055/s-0036-1593500
Wissen
Darm-Gehirn-Achse
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Die Rolle der Darm-Gehirn-Achse in der Pathophysiologie des Reizdarmsyndroms

Miriam Goebel-Stengel
,
Andreas Stengel
Subject Editor:
Further Information

Publication History

Publication Date:
28 September 2016 (online)

    Permissions and Reprints

Summary

Gehirn und Darm interagieren eng und wechselseitig miteinander, hierbei haben sich die Begriffe Gehirn-Darm-Achse, aber auch Darm-Gehirn-Achse durchgesetzt. Im Artikel werden entsprechende Veränderungen dieser Achse am Beispiel des Reizdarmsyndroms diskutiert. Abschließend werden therapeutische Ansätze, die die Darm-Gehirn-Achse beeinflussen, vorgestellt.

Keywords

Brain-Gut-Achse - CRF - endokrin - enterisches Nervensystem - Gastrointestinaltrakt - Hypothalamus - Mikrobiom-Darm-Gehirn-Achse - neuronal - Stress
 

  • Literatur

  • 1 Beaumont W. Experiments and Observations on the Gastric Juice and the Physiology of Digestion. South Bridge: Maclachlan & Stewart; 1838
    Google Scholar
  • 2 Pavlov IP. The Experimental Psychology and Psychopathology of Animals. The 14th International Medical Congress; April 23–30. Madrid, Spain: 1903
    Google Scholar
  • 3 Almy TP. Experimental studies on the irritable colon. Am J Med 1951; 10: 60-67
    CrossrefGoogle Scholar
  • 4 Banks WA. Evidence for a cholecystokinin gut-brain axis with modulation by bombesin. Peptides 1980; 1: 347-351
    CrossrefGoogle Scholar
  • 5 Pappas TN, Tache Y, Debas HT. Opposing central and peripheral actions of brain-gut peptides: a basis for regulation of gastric function. Surgery 1985; 98: 183-190
    Google Scholar
  • 6 Samson WK, Lumpkin MD, Vijayan E et al. Gastrointestinal hormones: central nervous system localization and sites of neuroendocrine actions. Endocrinol Exp 1982; 16: 177-189
    Google Scholar
  • 7 Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129-136
    CrossrefPubMedGoogle Scholar
  • 8 Rosenfeld CS. Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos 2015; 43: 1557-1571
    CrossrefGoogle Scholar
  • 9 Hamdani N, Boukouaci W, Hallouche MR et al. Resolution of a manic episode treated with activated charcoal: Evidence for a brain-gut axis in bipolar disorder. Aust N Z J Psychiatry 2015; 49: 1221-1223
    CrossrefGoogle Scholar
  • 10 Gorky J, Schwaber J. The role of the gut-brain axis in alcohol use disorders. Prog Neuropsychopharmacol Biol Psychiatry 2016; 65: 234-241
    CrossrefGoogle Scholar
  • 11 Wang PY, Caspi L, Lam CK et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008; 452: 1012-1016
    CrossrefGoogle Scholar
  • 12 Bonaz B. Inflammatory bowel diseases: a dysfunction of brain-gut interactions?. Minerva Gastroenterol Dietol 2013; 59: 241-259
    Google Scholar
  • 13 Candeias EM, Sebastiao IC, Cardoso SM et al. Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide. World J Diabetes 2015; 6: 807-827
    CrossrefPubMedGoogle Scholar
  • 14 Layer P, Andresen V, Pehl C et al. S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2011; 49: 237-293
    Google Scholar
  • 15 Palsson OS, Whitehead WE, van Tilburg MA et al. Rome IV Diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology 2016; DOI: 10.1053/j.gastro.2016.02.014.
    Google Scholar
  • 16 O’Mahony SM, Coelho AM, Fitzgerald P et al. The effects of gabapentin in two animal models of co-morbid anxiety and visceral hypersensitivity. Eur J Pharmacol 2011; 667: 169-174
    CrossrefGoogle Scholar
  • 17 Bradford K, Shih W, Videlock EJ et al. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol 2012; 10: 385-390
    CrossrefGoogle Scholar
  • 18 Waehrens R, Ohlsson H, Sundquist J et al. Risk of irritable bowel syndrome in first-degree, second-degree and third-degree relatives of affected individuals: a nationwide family study in Sweden. Gut 2015; 64: 215-221
    CrossrefGoogle Scholar
  • 19 Enck P, Merlin V, Erckenbrecht JF et al. Stress effects on gastrointestinal transit in the rat. Gut 1989; 30: 455-459
    CrossrefGoogle Scholar
  • 20 Spiess J, Rivier J, Rivier C et al. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 1981; 78: 6517-6521
    CrossrefGoogle Scholar
  • 21 Stengel A, Tache Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) 2010; 235: 1168-1178
    CrossrefGoogle Scholar
  • 22 Enck P, Aziz Q, Barbara G et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 2: 16014
    CrossrefGoogle Scholar
  • 23 Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-396
    CrossrefGoogle Scholar
  • 24 Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-742
    CrossrefPubMedGoogle Scholar
  • 25 Koloski NA, Jones M, Talley NJ. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment Pharmacol Ther 2016; 44: 592-600
    CrossrefGoogle Scholar
  • 26 Enck P, Junne F, Klosterhalfen S et al. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010; 22: 1402-1411
    Google Scholar
  • 27 Mazurak N, Broelz E, Storr M, Enck P. Probiotic therapy of the irritable bowel syndrome: Why is the evidence still poor and what can be done about it?. J Neurogastroenterol Motil 2015; 21: 471-485
    CrossrefGoogle Scholar
  • 28 Saito-Nakaya K, Hasegawa R, Nagura Y et al. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil 2008; 20: 1147-1156
    CrossrefGoogle Scholar
  • 29 van den Wijngaard RM, Stanisor OI, van Diest SA et al. Peripheral alpha-helical CRF (9–41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats. Neurogastroenterol Motil 2012; 24: 274-282
    CrossrefGoogle Scholar
  • 30 Wang X, Yin J. Complementary and alternative therapies for chronic constipation. Evid Based Complement Alternat Med 2015; DOI: 10.1155/2015/396396.
    Google Scholar
  • 31 Sun JH, Guo H, Chen L et al. [Effect of electroacupuncture at “Tianshu”(ST 25) on colonic smooth muscle structure and interstitial cells of cajal in slow transit constipation rats]. Zhen Ci Yan Jiu 2011; 36: 171-175
    Google Scholar
  • 32 Chao HL, Miao SJ, Liu PF et al. The beneficial effect of ST-36 (Zusanli) acupressure on postoperative gastrointestinal function in patients with colorectal cancer. Oncol Nurs Forum 2013; 40: E61-68
    CrossrefGoogle Scholar
  • 33 Iwa M, Matsushima M, Nakade Y et al. Electroacupuncture at ST-36 accelerates colonic motility and transit in freely moving conscious rats. Am J Physiol Gastrointest Liver Physiol 2006; 290: G285-292
    CrossrefGoogle Scholar
  • 34 Luo D, Liu S, Xie X, Hou X. Electroacupuncture at acupoint ST-36 promotes contractility of distal colon via a cholinergic pathway in conscious rats. Dig Dis Sci 2008; 53: 689-693
    CrossrefGoogle Scholar
  • 35 Li HJ, Li GP, Li HY. [Clinical observation on acupoint catgut embedding therapy for treatment of ulcerative colitis]. Zhongguo Zhen Jiu 2006; 26: 261-263
    Google Scholar
  • 36 Shi ZM, Zhu YS, Wang QX et al. [Comparative study on irritable bowel syndrome treated with acupuncture and western medicine]. Zhongguo Zhen Jiu 2011; 31: 607-609
    Google Scholar